Linda Van Eldik

3.9k total citations · 1 hit paper
12 papers, 2.9k citations indexed

About

Linda Van Eldik is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Linda Van Eldik has authored 12 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Linda Van Eldik's work include Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Linda Van Eldik is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Computational Drug Discovery Methods (3 papers) and Cholinesterase and Neurodegenerative Diseases (3 papers). Linda Van Eldik collaborates with scholars based in United States and Iraq. Linda Van Eldik's co-authors include Holly D. Oakley, Sreemathi Logan, Robert Vassar, Pei Shao, Sarah L. Cole, Angela Guillozet-Bongaarts, Erika Maus, R. Stephen Berry, John F. Disterhoft and Masuo Ohno and has published in prestigious journals such as Journal of Neuroscience, The FASEB Journal and Annals of the New York Academy of Sciences.

In The Last Decade

Linda Van Eldik

12 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

2006 2.5k citations Holly D. Oakley, Sarah L. Cole et al. Journal of Neuroscience profile →

Peers

Linda Van Eldik

PHYSI

MB

NEURO

CMN

PHARM

Pei Shao Canada

Scot Styren United States

Sylvain Lesné United States

Holly D. Oakley United States

Sreemathi Logan United States

Peter Borghgraef Belgium

Birgit Hutter‐Paier Austria

Lih-Fen Lue United States

Elena Marcello Italy

David Baglietto‐Vargas United States

Pei Shao Canada

Linda Van Eldik

1.8k ×0.9

PHYSI

826 ×0.9

MB

842 ×1.0

NEURO

711 ×1.0

CMN

391 ×0.9

PHARM

Citations per year, relative to Linda Van Eldik Linda Van Eldik (= 1×) peers Pei Shao

Countries citing papers authored by Linda Van Eldik

Since Specialization

Citations

This map shows the geographic impact of Linda Van Eldik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linda Van Eldik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linda Van Eldik more than expected).

Fields of papers citing papers by Linda Van Eldik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linda Van Eldik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linda Van Eldik. The network helps show where Linda Van Eldik may publish in the future.

Co-authorship network of co-authors of Linda Van Eldik

This figure shows the co-authorship network connecting the top 25 collaborators of Linda Van Eldik. A scholar is included among the top collaborators of Linda Van Eldik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linda Van Eldik. Linda Van Eldik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Smith, Charles D., Justin M. Barber, Omar Al‐Janabi, et al.. (2021). Development of a protocol to assess within-subject, regional white matter hyperintensity changes in aging and dementia. Journal of Neuroscience Methods. 360. 109270–109270. 5 indexed citations

2.

Jiang, Yang, Haiqing Huang, Erin L. Abner, et al.. (2016). Alzheimer’s Biomarkers are Correlated with Brain Connectivity in Older Adults Differentially during Resting and Task States. Frontiers in Aging Neuroscience. 8. 15–15. 25 indexed citations

3.

Webster, Scott J., et al.. (2014). P1‐097: TRAUMATIC BRAIN INJURY IN A MOUSE MODEL OF ALZHEIMER'S DISEASE LEADS TO PERSISTENT GLIAL ACTIVATION, CHRONIC PROINFLAMMATORY PHENOTYPE, AND INCREASED COGNITIVE DEFICITS. Alzheimer s & Dementia. 10(4S_Part_9). 3 indexed citations

4.

LaDu, Mary Jo, Susan L. Wohlgenant, Linda Van Eldik, & Leon M. Tai. (2014). TLR4‐p38 pathway as a mechanism of APOE‐modulated neuroinflammation in Alzheimer disease (1056.6). The FASEB Journal. 28(S1). 1 indexed citations

5.

Howell, Gareth R., et al.. (2010). Assessing Microglia/Macrophages in DBA/2J Glaucoma. Investigative Ophthalmology & Visual Science. 51(13). 2098–2098. 2 indexed citations

6.

Oakley, Holly D., Sarah L. Cole, Sreemathi Logan, et al.. (2006). Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation. Journal of Neuroscience. 26(40). 10129–10140. 2544 indexed citations breakdown →

7.

Behanna, Heather A., et al.. (2006). De Novo and Molecular Target-Independent Discovery of Orally Bioavailable Lead Compounds for Neurological Disorders. Current Alzheimer Research. 3(3). 205–214. 26 indexed citations

8.

Hu, Wenhui, Hantamalala Ralay Ranaivo, Jeffrey M. Craft, Linda Van Eldik, & D. Martin Watterson. (2005). Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimers Disease-Related Mouse Model. Current Alzheimer Research. 2(2). 197–205. 16 indexed citations

9.

Fillit, Howard, Alan W. O’Connell, William M. Brown, et al.. (2002). Barriers to Drug Discovery and Development for Alzheimer Disease. Alzheimer Disease & Associated Disorders. 16. S1–S8. 18 indexed citations

10.

Engelhard, Herbert H., et al.. (2001). Therapeutic Effects of Sodium Butyrate on Glioma Cells in Vitro and in the Rat C6 Glioma Model. Neurosurgery. 48(3). 616–625. 36 indexed citations

11.

LaDu, Mary Jo, Catherine A. Reardon, Linda Van Eldik, et al.. (2000). Lipoproteins in the Central Nervous System. Annals of the New York Academy of Sciences. 903(1). 167–175. 173 indexed citations

12.

Sorge, Laurie K., Linda Van Eldik, & Patricia F. Maness. (1985). A calmodulin-dependent protein kinase in Rous sarcoma virus-transformed rat cells and normal liver. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 844(2). 174–181. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact